Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

S. Daenen; B. van der Holt; A.W. Dekker; R. Willemze; A.W. Rijneveld; B.J. Biemond; P. Muus; A.A. van de Loosdrecht; H.C. Schouten; M. van Marwijk Kooy; D.A. Breems; H. Demuynck; J. Maertens; P.W. Wijermans; S. Wittebol; E.W. de Klerk; x HOVON Dutch-Belgian Hematology-Oncology Group; J.J. Cornelissen

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

S. Daenen, B. van der Holt, A.W. Dekker, R. Willemze, A.W. Rijneveld, B.J. Biemond, P. Muus, A.A. van de Loosdrecht, H.C. Schouten, M. van Marwijk Kooy, D.A. Breems, H. Demuynck, J. Maertens, P.W. Wijermans, S. Wittebol, E.W. de Klerk, x HOVON Dutch-Belgian Hematology-Oncology Group, J.J. Cornelissen

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1726-1729
Number of pages	4
Journal	Leukemia
Volume	26
Issue number	7
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22358264

Cite this

Daenen, S., van der Holt, B., Dekker, A. W., Willemze, R., Rijneveld, A. W., Biemond, B. J., Muus, P., van de Loosdrecht, A. A., Schouten, H. C., van Marwijk Kooy, M., Breems, D. A., Demuynck, H., Maertens, J., Wijermans, P. W., Wittebol, S., de Klerk, E. W., HOVON Dutch-Belgian Hematology-Oncology Group, X., & Cornelissen, J. J. (2012). Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. Leukemia, 26(7), 1726-1729. http://www.ncbi.nlm.nih.gov/pubmed/22358264

@article{16ab189442334417877b061ee76813d8,

title = "Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.",

author = "S. Daenen and {van der Holt}, B. and A.W. Dekker and R. Willemze and A.W. Rijneveld and B.J. Biemond and P. Muus and {van de Loosdrecht}, A.A. and H.C. Schouten and {van Marwijk Kooy}, M. and D.A. Breems and H. Demuynck and J. Maertens and P.W. Wijermans and S. Wittebol and {de Klerk}, E.W. and {HOVON Dutch-Belgian Hematology-Oncology Group}, x and J.J. Cornelissen",

year = "2012",

language = "English",

volume = "26",

pages = "1726--1729",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

Daenen, S, van der Holt, B, Dekker, AW, Willemze, R, Rijneveld, AW, Biemond, BJ, Muus, P, van de Loosdrecht, AA, Schouten, HC, van Marwijk Kooy, M, Breems, DA, Demuynck, H, Maertens, J, Wijermans, PW, Wittebol, S, de Klerk, EW, HOVON Dutch-Belgian Hematology-Oncology Group, X & Cornelissen, JJ 2012, 'Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.', Leukemia, vol. 26, no. 7, pp. 1726-1729. <http://www.ncbi.nlm.nih.gov/pubmed/22358264>

TY - JOUR

T1 - Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

AU - Daenen, S.

AU - van der Holt, B.

AU - Dekker, A.W.

AU - Willemze, R.

AU - Rijneveld, A.W.

AU - Biemond, B.J.

AU - Muus, P.

AU - van de Loosdrecht, A.A.

AU - Schouten, H.C.

AU - van Marwijk Kooy, M.

AU - Breems, D.A.

AU - Demuynck, H.

AU - Maertens, J.

AU - Wijermans, P.W.

AU - Wittebol, S.

AU - de Klerk, E.W.

AU - HOVON Dutch-Belgian Hematology-Oncology Group, x

AU - Cornelissen, J.J.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0887-6924

VL - 26

SP - 1726

EP - 1729

JO - Leukemia

JF - Leukemia

IS - 7

ER -